Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis.

Res Pract Thromb Haemost · 2024 · PMC11127259 · PMID 38798793

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

There was a notable trend over time in favor of DOACs as the preferred anticoagulant prescribed, while warfarin utilization was minimal later in the study period.

also in 2,041 other papers

a significant trendno p-value reported

A significant trend showed that DOACs are increasingly prescribed as anticoagulant thromboprophylaxis over warfarin and LMWH in recent years.

also in 4,888 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.